Founded On Pioneering Research By Riitta Lassila And Associates At The Wihuri Research Institute In Helsinkiaplagon Is A Clinical Stage Biopharmaceutical Company Dedicated To Developing First In Class Therapeutics For Thromboinflammatory Diseasesaddressing Critical Unmet Medical Needs In Vascular Medicine Its Lead Therapeuticapaca Heparin Proteoglycan Mimeticis A Dual Antiplatelet And Anticoagulantapacwith Unique Antithrombotic And Anti Inflammatory Propertiesdesigned To Specifically Target Vascular Injury Sitesapac Provides Localizedlong Term Action While Minimizing Systemic Exposure The Company S Clinical Pipeline Focuses On Addressing Thromboinflammatory Conditionswith Lead Indications In Arteriovenous Fistulaavfmaturation Failure For Hemodialysis Patients And Chronic Limb Threatening Ischemiacltito Prevent Amputations And Major Cardiovascular Events
No conferences found for this company.
| Company Name | Aplagon Oy |
| Country |
Finland
|
| Address | Iso Roobertinkatu 35D 10Helsinki 00120Finland |
| Telephone | Login to View |
| Login to View |
